Boryung Corporation

KSE 003850.KS

Boryung Corporation Return on Assets (ROA) for the year ending December 31, 2023: 4.39%

Boryung Corporation Return on Assets (ROA) is 4.39% for the year ending December 31, 2023, a -6.46% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Boryung Corporation Return on Assets (ROA) for the year ending December 31, 2022 was 4.69%, a -9.62% change year over year.
Boryung Corporation Return on Assets (ROA) for the year ending December 31, 2021 was 5.19%, a 25.34% change year over year.
Boryung Corporation Return on Assets (ROA) for the year ending December 31, 2020 was 4.14%, a -34.71% change year over year.
Boryung Corporation Return on Assets (ROA) for the year ending December 31, 2019 was 6.35%, a 40.67% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

KSE: 003850.KS

Boryung Corporation

CEO	Mr. Jay Kim
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	136, Changgyeonggung-ro
Employees	1,533
Sector	Health Care
Industries Pharmaceuticals

Description

Boryung Corporation produces and sells pharmaceutical products in South Korea. The company offers cardiovascular products, anticancer products, gastrointestinal products, and API's. It also exports its products to approximately 50 countries on 6 continents, including Japan, China, the Southeast Asia, the Middle East, Europe, South America, and Africa. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is based in Seoul, South Korea.

Key trends

Past 5 years